Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis



Rating:

Share or cite this content

Citations should be made in the following way:
G. Karoubi, A. Huber, L. Cortes-Dericks, I. Breyer, R. Schmid, A. Dutly (Berne, Switzerland). Oral presentation: Human lung parenchyma cells: a potential therapeutic cell source for lung disease. Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis

Member's Comments

No comment yet.

Related content which might interest you: Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Fibrosis-specific stem-like cells in peripheral IPF lung: Characteristics and potential role Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Epithelial cell migration as a potential therapeutic target in early lung cancer Source: Eur Respir Rev 2017; 26: 160069 Year: 2017 Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer? Source: International Congress 2016 – Mechanisms of disease Year: 2016 Intersections of lung progenitor cells, lung disease and lung cancer Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017 Year: 2017 Systemic treatment of small cell lung cancer Source: Annual Congress 2008 - PG6 - Thoracic oncology: new treatments for thoracic malignancies (other than nonsmall cell lung cancer) Year: 2008 Systemic therapy. non small cell lung cancer stage I and II: treatment standards and new development Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Immunosuppressive properties of bronchial epithelial cells are altered in lung transplant recipients: “ex-vivo” model of T cell-allogeneic response Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction Year: 2013 Intratracheal application of healthy lung derived Mesenchymal Stem Cells (DON-MSC) in the form of biospheres (BS) as potential therapeutic agents for chronic lung disease Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Surgery for non small cell lung cancer (NSCLC) and functional limits: is there a possible beneficial role of preoperative pulmonary rehabilitation? Source: Eur Respir J 2004; 24: Suppl. 48, 522s Year: 2004 Mast cells in lung disease: clinical implications Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Source: Eur Respir J 2010; 35: 496-504 Year: 2010 Stem cells, lung pathogenesis and therapeutic potential Source: Annual Congress 2005 - Scientific year in review Year: 2005 “Scar-cinoma”: viewing the fibrotic lung mesenchymal cell in the context of cancer biology Source: Eur Respir J 2016; 47:1842-1854 Year: 2016 Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Single cell analysis of human lung development: knowing what mesenchymal cells are and what they may be Source: Eur Respir J, 55 (1) 1902327; 10.1183/13993003.02327-2019 Year: 2020 Efficacy of functionalized-imatinib loaded gold nanoparticles on lung fibroblastoid cells from systemic sclerosis patients Source: International Congress 2016 – Connective tissue disorders Year: 2016